Virpax Pharmaceuticals (VRPX) Receives FDA Response and Guidance on MMS019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Virpax Pharmaceuticals (VRPX) halted on LUDP
August 18, 2021 9:40 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) halted on LUDP
... MoreSmall-cap Virpax (VRPX) Up 100% Today to Push Weekly Gains to Over 500% After Receiving FDA Guidance on SARS and Flu Treatment
August 18, 2021 9:36 AM EDTShares of Virpax Pharmaceuticals (NASDAQ: VRPX) are trading higher after the company said it received a guided response from the US Food and Drug Administration (FDA) concerning its treatment that protects against SARS and flu.
The FDA response brings clarity about MMS019, a... More
Virpax Pharmaceuticals (VRPX) Extends Gain, Now Up 140%
August 18, 2021 7:27 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) Extends Gain, Now Up 140%
Virpax Pharmaceuticals (VRPX) Extends Yesterday's Gain, Up Another 65%
August 18, 2021 6:07 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) Extends Yesterday's Gain, Up Another 65%
Shares were Up 265% Yesterday... More
